A robust gene signature for the prediction of early relapse in stage I–III colon cancer

Colon cancer patients experiencing early relapse consistently exhibited poor survival. The aim of our study was to develop an mRNA signature that can help to detect early relapse cases in stage I–III colon cancer. Public microarray datasets of stage I–III colon cancer samples were extracted from the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Oncol
Main Authors: Dai, Weixing, Li, Yaqi, Mo, Shaobo, Feng, Yang, Zhang, Long, Xu, Ye, Li, Qingguo, Cai, Guoxiang
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5891048/
https://ncbi.nlm.nih.gov/pubmed/29377588
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12175
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados